{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:11:34Z","timestamp":1790277094294,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01889-2","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:33:39Z","timestamp":1762875219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The biological scaling of Alzheimer\u2019s disease neuropathological changes across primate species"],"prefix":"10.1186","volume":"17","author":[{"given":"Clara","family":"Toussaint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"B\u00e9zard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00ebl","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Planche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"1889_CR1","first-page":"748","volume":"40","author":"J Gayon","year":"2000","unstructured":"Gayon J. History of the concept of allometry1. Am Zool. 2000;40:748\u201358.","journal-title":"Am Zool"},{"key":"1889_CR2","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16302","volume":"31","author":"N Villain","year":"2024","unstructured":"Villain N, Michalon R. What is alzheimer\u2019s disease? An analysis of nosological perspectives from the 20th and 21st centuries. Eur J Neurol. 2024;31:e16302.","journal-title":"Eur J Neurol"},{"key":"1889_CR3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet. 2024;404:572\u2013628.","journal-title":"Lancet"},{"key":"1889_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134:187\u2013205.","journal-title":"Acta Neuropathol"},{"key":"1889_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70:960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1889_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:1\u201313.","journal-title":"Alzheimers Dement"},{"key":"1889_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neurobiolaging.2017.07.006","volume":"59","author":"MK Edler","year":"2017","unstructured":"Edler MK, Sherwood CC, Meindl RS, Hopkins WD, Ely JJ, Erwin JM, et al. Aged chimpanzees exhibit pathologic hallmarks of Alzheimer\u2019s disease. Neurobiol Aging. 2017;59:107\u201320.","journal-title":"Neurobiol Aging"},{"key":"1889_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neurobiolaging.2016.04.019","volume":"44","author":"RF Rosen","year":"2016","unstructured":"Rosen RF, Tomidokoro Y, Farberg AS, Dooyema J, Ciliax B, Preuss TM, et al. Comparative pathobiology of \u03b2-amyloid and the unique susceptibility of humans to Alzheimer\u2019s disease. Neurobiol Aging. 2016;44:185\u201396.","journal-title":"Neurobiol Aging"},{"key":"1889_CR9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molmed.2017.04.001","volume":"23","author":"LC Walker","year":"2017","unstructured":"Walker LC, Jucker M. The exceptional vulnerability of humans to Alzheimer\u2019s disease. Trends Mol Med. 2017;23:534\u201345.","journal-title":"Trends Mol Med"},{"key":"1889_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0014-5793(95)01491-8","volume":"379","author":"L Morelli","year":"1996","unstructured":"Morelli L, Wei L, Amorim A, McDermid J, Abee CR, Frangione B, et al. Cerebrovascular amyloidosis in squirrel monkeys and rhesus monkeys: apolipoprotein E genotype. FEBS Lett. 1996;379:132\u20134.","journal-title":"FEBS Lett"},{"key":"1889_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2011.01246.x","volume":"38","author":"M Ndung\u2019u","year":"2012","unstructured":"Ndung\u2019u M, H\u00e4rtig W, Wegner F, Mwenda JM, Low RWC, Akinyemi RO, et al. Cerebral amyloid \u03b2(42) deposits and microvascular pathology in ageing baboons. Neuropathol Appl Neurobiol. 2012;38:487\u201399.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1889_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s004010100429","volume":"103","author":"C Geula","year":"2002","unstructured":"Geula C, Nagykery N, Wu C-K. Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol. 2002;103:48\u201358.","journal-title":"Acta Neuropathol"},{"key":"1889_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/rej.2008.0677","volume":"11","author":"CA Lemere","year":"2008","unstructured":"Lemere CA, Oh J, Stanish HA, Peng Y, Pepivani I, Fagan AM, et al. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer\u2019s disease? Rejuvenation Res. 2008;11:321\u201332.","journal-title":"Rejuvenation Res"},{"key":"1889_CR14","volume":"86","author":"SH Kim","year":"2025","unstructured":"Kim SH, Hao J. Recent advances in diagnostic and therapeutic strategies for canine cognitive dysfunction. Am J Vet Res. 2025;86:ajvr.25.02.0053.","journal-title":"Am J Vet Res"},{"key":"1889_CR15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ejn.15900","volume":"57","author":"MC Vacher","year":"2023","unstructured":"Vacher MC, Durrant CS, Rose J, Hall AJ, Spires-Jones TL, Gunn-Moore F, et al. Alzheimer\u2019s disease-like neuropathology in three species of oceanic dolphin. Eur J Neurosci. 2023;57:1161\u201379.","journal-title":"Eur J Neurosci"},{"key":"1889_CR16","volume":"382","author":"BM Wood","year":"2023","unstructured":"Wood BM, Negrey JD, Brown JL, Deschner T, Thompson ME, Gunter S, et al. Demographic and hormonal evidence for menopause in wild chimpanzees. Science. 2023;382:eadd5473.","journal-title":"Science"},{"key":"1889_CR17","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1073\/pnas.1902452116","volume":"116","author":"K Whittemore","year":"2019","unstructured":"Whittemore K, Vera E, Mart\u00ednez-Nevado E, Sanpera C, Blasco MA. Telomere shortening rate predicts species life span. Proc Natl Acad Sci U S A. 2019;116:15122\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1889_CR18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1124\/dmd.114.058404","volume":"42","author":"AS Darwich","year":"2014","unstructured":"Darwich AS, Aslam U, Ashcroft DM, Rostami-Hodjegan A. Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans. Drug Metab Dispos. 2014;42:2016\u201322.","journal-title":"Drug Metab Dispos"},{"key":"1889_CR19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh1448","volume":"7","author":"G Meisl","year":"2021","unstructured":"Meisl G, Hidari E, Allinson K, Rittman T, DeVos SL, Sanchez JS, et al. In vivo rate-determining steps of Tau seed accumulation in Alzheimer\u2019s disease. Sci Adv. 2021;7:eabh1448.","journal-title":"Sci Adv"},{"key":"1889_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"1889_CR21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:280\u201392.","journal-title":"Alzheimers Dement"},{"key":"1889_CR22","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2666-7568(23)00019-3","volume":"4","author":"E Nichols","year":"2023","unstructured":"Nichols E, Merrick R, Hay SI, Himali D, Himali JJ, Hunter S, et al. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia. Lancet Healthy Longev. 2023;4:e115\u201325.","journal-title":"Lancet Healthy Longev"},{"key":"1889_CR23","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3233\/JAD-160425","volume":"54","author":"P Wijesinghe","year":"2016","unstructured":"Wijesinghe P, Shankar SK, Yasha TC, Gorrie C, Amaratunga D, Hulathduwa S, et al. Vascular contributions in Alzheimer\u2019s Disease-related neuropathological changes: first autopsy evidence from a South Asian aging population. J Alzheimers Dis. 2016;54:1607\u201318.","journal-title":"J Alzheimers Dis"},{"key":"1889_CR24","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","volume":"360","author":"GM Savva","year":"2009","unstructured":"Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med. 2009;360:2302\u20139.","journal-title":"N Engl J Med"},{"key":"1889_CR25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and Tau in alzheimer\u2019s disease. Nat Neurosci. 2020;23:1183\u201393.","journal-title":"Nat Neurosci"},{"key":"1889_CR26","doi-asserted-by":"crossref","unstructured":"Darricau M, Dou C, Kinet R, Zhu T, Zhou L, Li X et al. Tau seeds from alzheimer\u2019s disease brains trigger Tau spread in macaques while oligomeric-A\u03b2 mediates pathology maturation. Alzheimers Dement. 2023.","DOI":"10.1002\/alz.13604"},{"key":"1889_CR27","doi-asserted-by":"crossref","unstructured":"Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D et al. Alzheimer disease as a Clinical-Biological Construct-An international working group recommendation. JAMA Neurol. 2024.","DOI":"10.1001\/jamaneurol.2024.3770"},{"key":"1889_CR28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41582-024-01004-3","volume":"20","author":"N Villain","year":"2024","unstructured":"Villain N, Planche V. Disentangling clinical and biological trajectories of neurodegenerative diseases. Nat Rev Neurol. 2024;20:693\u20134.","journal-title":"Nat Rev Neurol"},{"key":"1889_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/ADR-230184","volume":"8","author":"JL Thomas","year":"2024","unstructured":"Thomas JL, Nilaver BI, Lomniczi A, Brown DI, Appleman M-L, Kohama SG, et al. Pathological markers of Alzheimer\u2019s disease and related dementia in the rhesus macaque amygdala. J Alzheimers Dis Rep. 2024;8:25\u201332.","journal-title":"J Alzheimers Dis Rep"},{"key":"1889_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2021.07.009","volume":"107","author":"M Darricau","year":"2021","unstructured":"Darricau M, Canron M-H, Bosc M, Arot\u00e7arena M-L, Quang ML, Dehay B, et al. Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment. Neurobiol Aging. 2021;107:53\u20136.","journal-title":"Neurobiol Aging"},{"key":"1889_CR31","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J. 2017;36:2473\u201387.","journal-title":"EMBO J"},{"key":"1889_CR32","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimers Dement. 2021;17:1554\u201374.","journal-title":"Alzheimers Dement"},{"key":"1889_CR33","volume":"532","author":"CA Barnes","year":"2024","unstructured":"Barnes CA, Permenter MR, Vogt JA, Chen K, Beach TG. Human alzheimer\u2019s disease ATN\/ABC staging applied to aging rhesus macaque brains: association with cognition and MRI-based regional gray matter volume. J Comp Neurol. 2024;532:e25670.","journal-title":"J Comp Neurol"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01889-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:33:44Z","timestamp":1762875224000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01889-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01889-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"E.B. is a director and shareholder of Motac Neuroscience Ltd. During the past 3 years, V.P. was a local unpaid investigator or sub-investigator for clinical trials granted by Novo Nordisk, Biogen, Janssen, and Alector. V.P. served as a consultant for Motac Neuroscience Ltd, outside the submitted work. Other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}